The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

Older adults are being warned against receiving the chikungunya vaccine before traveling. The Ixchiq vaccination, developed ...

U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible ...

The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.

The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...

Health and Human Services Secretary Robert Kennedy Jr. defended proposed 2026 budget reductions during separate House and ...

Researchers say they've discovered an already approved migraine drug that can stop symptoms hours before a severe headache ...

Priorix was first launched in Europe almost a quarter of a century ago by GSK's predecessor SmithKline Beecham, and is a combination measles, mumps and rubella (MMR) vaccine now cleared by the FDA ...

GlaxoSmithKline has found a replacement for head of vaccines R&D Emmanuel Hanon, who left the company for a US biotech earlier this year, hiring Phil Dormitzer from ...